言語を選択
新規登録
お気に入りに追加

Human CD39 / ENTPD1 (Q96A, N99A, E143A, R147E) Protein, His Tag (active enzyme, MALS verified)

COADS MS
DS

ユーザーレビュー
製品番号/仕様
価格
数量
CD9-H52H5-100ug
$410.00
CD9-H52H5-1mg
$2680.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0
推奨新製品
関連アイテム

製品詳細

  • Synonyms

    CD39, ENTPD1, NTPDase 1, Entpd1, Ecto-ATPDase 1, Ecto-ATPase 1

  • Source

    Human CD39 (Q96A, N99A, E143A, R147E) Protein, His Tag (CD9-H52H5) is expressed from human 293 cells (HEK293). It contains AA Thr 38 - Val 478 (Accession # P49961-1 (Q96A, N99A, E143A, R147E)).

    Request for sequence

  • Molecular Characterization

    CD39 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 52.1 kDa. The protein migrates as 60-70 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Supplied as 0.2 μm filtered solution in 20 mM Tris,150 mM NaCl,pH8.0 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    CD39 SDS-PAGE

    Human CD39 (Q96A, N99A, E143A, R147E) Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • SEC-MALS

    CD39 SEC-MALS

    The purity of Human CD39 (Q96A, N99A, E143A, R147E) Protein, His Tag (Cat. No. CD9-H52H5) is more than 90% and the molecular weight of this protein is around 65-85 kDa verified by SEC-MALS.

    Report

  • Bioactivity-ELISA

    CD39 ELISA

    Immobilized Human CD39 / ENTPD1 (Q96A, N99A, E143A, R147E), His Tag (Cat. No. CD9-H52H5) at 1 μg/mL (100 μL/well) can bind X-IgG1 with a linear range of 0.5-3 ng/mL (Routinely tested).

    Protocol

  • Bioactivity

    Measured by its ability to hydrolyze the 5’-phosphate group from the substrate adenosine-5’-triphosphate (ATP). The specific activity is > 8,000 pmol/min/μg (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

CD39 is also known as Ectonucleoside triphosphate diphosphohydrolase 1, ENTPD1, NTPDase 1, Ecto-ATPDase 1, in the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Could also be implicated in the prevention of platelet aggregation by hydrolyzing platelet-activating ADP to AMP. Hydrolyzes ATP and ADP equally well. NTPDase-1 was originally described as CD39, a B lymphocyte cell surface marker, but it is also present on the surface of natural killer cells, T cells, and some endothelial cells.Regulatory T cells(Tregs) mediate immunosuppression through multiple, non-redundant, cell-contact dependent and independent mechanisms, a growing body of evidence suggests an important role for the CD39-CD73-adenosine pathway. CD39 ectonucleotidase is the rate-limiting enzyme of a cascade leading to the generation of suppressive adenosine that alters CD4 and CD8 T cell and natural killer cell antitumor activities.

最新の進展

 
医薬品開発の進捗
  • 英語名：

    Ectonucleoside triphosphate diphosphohydrolase 1

  • カテゴリ：

  • 市販の医薬品数：

    0 詳細

  • 治験医薬品数：

    11 詳細

  • 最新の開発ステージ：

    Phase 2 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8